The Innovation Pipeline: Future Drug and Device Advancements in Dysphagia
The **Esophageal Dysphagia Market** is on the cusp of a major wave of innovation, fueled by robust R&D pipelines focused on both highly specific drug therapies and next-generation interventional devices. In the pharmaceutical realm, the focus is heavily on targeted biologics for inflammatory causes like Eosinophilic Esophagitis (EoE), with multiple new monoclonal antibodies targeting...
0 Comments 0 Shares 33 Views 0 Reviews